In Silico Approaches to Nitrosamine Risk Assessment — 2026 Webinar Series
Nitrosamines continue to be one of the most challenging cross-functional issues facing the pharmaceutical industry, touching safety, quality, process development, and regulatory strategy. This webinar series explores how in silico tools can support confident nitrosamine risk assessment in the pharmaceutical product lifecycle.
Throughout 2026, experts from toxicology, CMC, and regulatory science will share practical insights into the formation of nitrosamines, acceptable intake calculations, qualification strategies, and control approaches. The series will highlight how in silico methods with Lhasa, streamline decision-making, reduce uncertainty, and support evolving regulatory expectations.
Who should attend: Professionals in toxicology, CMC, quality, risk assessment, regulatory affairs, API development, and related functions.
Registration: Register and indicate your areas of interest to receive updates on dates, speakers, and session access links. All sessions are virtual and free to attend.